Target intelligence / Profile preview

Pro-inflammatory pathways in human gingival keratinocytes

Molecular classification
Signaling pathway, Inflammatory cascade, Intracellular signaling network
01

Overview

Pro-inflammatory pathways in human gingival keratinocytes (HGKs) represent the complex signaling networks, such as the NF-kappaB and MAPK cascades, that mediate the oral epithelial response to bacterial pathogens like Porphyromonas gingivalis (Yoshioka et al., 2008, PMID: 18435973). These pathways are typically initiated when Toll-like receptors (TLRs), specifically TLR2 and TLR4, detect microbial components, leading to the nuclear translocation of transcription factors (Uehara et al., 2002, PMID: 12117491). This process results in the elevated production of pro-inflammatory cytokines, including IL-1beta, IL-6, and IL-8, which are critical mediators of the host immune response in the gingiva (Becerik et al., 2011, PMID: 21291396). Chronic activation of these pathways is a primary driver of periodontal disease progression, characterized by tissue degradation and alveolar bone loss. Therapeutic approaches often involve the use of anti-inflammatory agents or specialized pro-resolving mediators to dampen these signaling cascades and prevent collateral tissue damage. While not a single molecular target, these pathways contain numerous druggable nodes essential for managing oral inflammatory conditions.

Other names
Gingival inflammatory signalingOral epithelial pro-inflammatory cascadesKeratinocyte inflammatory pathwaysGingival innate immune response pathways
02

Mechanism of action

Modulation of intracellular signaling cascades, including the inhibition of NF-kappaB translocation and MAPK phosphorylation, to reduce the expression of pro-inflammatory cytokines and matrix metalloproteinases.

03

Biological functions

Immune responseSignal transductionCytokine productionCellular stress responseApoptosis
04

Disease associations

PeriodontitisGingivitisOral lichen planusOral mucositisPeri-implantitis
05

Safety considerations

Localized immunosuppressionDelayed mucosal wound healingAlteration of the oral microbiomeRisk of opportunistic oral infections (e.g., Candidiasis)
06

Interacting drugs

Dexamethasone

4 more in the full profile.

07

Biomarkers

Interleukin-1 beta (IL-1beta)Interleukin-6 (IL-6)Interleukin-8 (IL-8)Tumor necrosis factor-alpha (TNF-alpha)Matrix metalloproteinase-9 (MMP-9)

Beyond the preview

Go deeper on Pro-inflammatory pathways in human gingival keratinocytes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pro-inflammatory pathways in human gingival keratinocytes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call